Prevention and Management of Influenza Type Illness and Strengthening of Argentina's Epidemiological System Project

Development Objective

The objective of the Project is to strengthen the capacity of the Borrower’s epidemiological health surveillance system to: (a) prevent, monitor and evaluate influenza activity and (b) control epidemic waves of A/H1N1 influenza.

Key Details

Project Details

Project ID
P117377
Status
Closed
Team Leader
Vanina Camporeale
Borrower 2
N/A

Country
Argentina
Disclosure Date
February 4, 2010
Approval Date
(as of board presentation)
February 23, 2010
Effective Date
April 14, 2010

Total Project Cost 1
US$ 229.00 million
Implementing Agency
N/A
Region
Latin America and Caribbean
Fiscal Year 3
2010

Commitment Amount
US$ 141.00 million
Environmental Category
B
Environmental and Social Risk
Not Applicable
Closing Date
December 31, 2013

Last Stage Reached
BANK APPROVED
Last Update Date
June 13, 2016

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control19%
FY17 - Health Systems and Policies81%
- FY17 - Health System Strengthening81%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
International Bank for Reconstruction and Development	141.00
Borrower/Recipient	88.00

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	141.00
IDA Commitment	N/A
IBRD + IDA Commitment	141.00

Lending Instrument
Grant Amount	N/A
Total Project Cost**	229.00

Summary Status of World Bank Financing (US$ Millions) as of July 31, 2025

No data available.

Detailed Financial Activity as of July 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Sep 15, 2021	IBRD-78430	Loan Repay	931,942.90
Sep 15, 2021	IBRD-78430	Loan Repay	123,990.60
Sep 15, 2021	IBRD-78430	Loan Repay	1,611,000.40
Sep 15, 2021	IBRD-78430	Loan Repay	29,075.52
Mar 15, 2022	IBRD-78430	Int Charges	1,567,459.90
Mar 15, 2022	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2022	IBRD-78430	Loan Repay	1,004,558.94
Mar 15, 2022	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2022	IBRD-78430	Loan Repay	1,567,459.90
Mar 15, 2022	IBRD-78430	Int Charges	26,930.75
Sep 15, 2017	IBRD-78430	Loan Repay	123,990.60
Sep 15, 2017	IBRD-78430	Loan Repay	665,960.30
Mar 15, 2018	IBRD-78430	Int Charges	1,683,214.00
Mar 15, 2018	IBRD-78430	Int Charges	232,570.31
Mar 15, 2018	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2018	IBRD-78430	Loan Repay	788,901.56
Mar 15, 2018	IBRD-78430	Loan Repay	835,329.80
Mar 15, 2018	IBRD-78430	Loan Repay	1,015,734.44
Mar 15, 2017	IBRD-78430	Loan Repay	627,188.56
Sep 15, 2016	IBRD-78430	Int Charges	58,379.18
Sep 15, 2016	IBRD-78430	Int Charges	2,046,406.00
Sep 15, 2016	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2017	IBRD-78430	Int Charges	65,955.41
Mar 15, 2017	IBRD-78430	Int Charges	2,002,865.40
Mar 15, 2017	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2017	IBRD-78430	Loan Repay	2,068,820.80
Mar 15, 2016	IBRD-78430	Int Charges	2,089,946.50
Mar 15, 2016	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2016	IBRD-78430	Loan Repay	2,696,009.50
Mar 15, 2016	IBRD-78430	Int Charges	47,840.52
Sep 15, 2016	IBRD-78430	Loan Repay	591,224.25
Sep 15, 2016	IBRD-78430	Loan Repay	2,104,785.20
Sep 15, 2015	IBRD-78430	Int Charges	45,026.52
Sep 15, 2015	IBRD-78430	Int Charges	2,133,487.00
Sep 15, 2015	IBRD-78430	Loan Repay	123,990.60
Sep 15, 2015	IBRD-78430	Loan Repay	2,696,009.50
Sep 15, 2014	IBRD-78430	Int Charges	43,727.36
Sep 15, 2014	IBRD-78430	Int Charges	2,177,027.50
Sep 15, 2020	IBRD-78430	Int Charges	44,240.66
Sep 15, 2020	IBRD-78430	Int Charges	1,698,081.50
Sep 15, 2020	IBRD-78430	Loan Repay	123,990.60
Sep 15, 2020	IBRD-78430	Loan Repay	953,687.20
Sep 15, 2020	IBRD-78430	Loan Repay	1,742,322.20
Mar 15, 2021	IBRD-78430	Int Charges	1,654,541.00
Mar 15, 2021	IBRD-78430	Int Charges	31,506.49
Mar 15, 2021	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2021	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2021	IBRD-78430	Loan Repay	2,572,018.80
Sep 15, 2019	IBRD-78430	Int Charges	96,916.30
Sep 15, 2019	IBRD-78430	Int Charges	773,087.50
Sep 15, 2019	IBRD-78430	Int Charges	1,012,075.06
Sep 15, 2019	IBRD-78430	Loan Repay	2,696,009.50
Sep 15, 2019	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2020	IBRD-78430	Int Charges	77,728.32
Mar 15, 2020	IBRD-78430	Int Charges	1,741,622.10
Mar 15, 2020	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2020	IBRD-78430	Loan Repay	752,668.40
Mar 15, 2020	IBRD-78430	Loan Repay	77,728.32
Mar 15, 2020	IBRD-78430	Loan Repay	1,741,622.10
Mar 15, 2020	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2019	IBRD-78430	Loan Repay	1,923,484.50
Mar 15, 2019	IBRD-78430	Loan Repay	772,524.94
Mar 15, 2019	IBRD-78430	Int Charges	94,781.30
Mar 15, 2019	IBRD-78430	Int Charges	1,828,703.10
Mar 15, 2019	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2018	IBRD-78430	Loan Repay	56,043.55
Mar 15, 2018	IBRD-78430	Int Charges	68,847.99
Feb 23, 2010	IBRD-78430	Loan Commitment	229,000,000.00
Mar 15, 2024	IBRD-78430	Int Charges	137,189.12
Mar 15, 2024	IBRD-78430	Int Charges	1,393,297.60
Mar 15, 2024	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2024	IBRD-78430	Loan Repay	2,696,009.50
Mar 15, 2023	IBRD-78430	Int Charges	103,646.03
Mar 15, 2023	IBRD-78430	Int Charges	1,480,378.80
Mar 15, 2023	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2023	IBRD-78430	Loan Repay	2,696,009.50
Sep 15, 2023	IBRD-78430	Loan Repay	2,696,009.50
Sep 15, 2023	IBRD-78430	Int Charges	127,569.80
Sep 15, 2023	IBRD-78430	Int Charges	1,436,838.10
Sep 15, 2023	IBRD-78430	Loan Repay	123,990.60
Sep 15, 2022	IBRD-78430	Int Charges	48,353.60
Sep 15, 2022	IBRD-78430	Int Charges	1,475,565.80
Sep 15, 2022	IBRD-78430	Int Charges	48,353.60
Sep 15, 2022	IBRD-78430	Loan Repay	123,990.60
Sep 15, 2022	IBRD-78430	Loan Repay	2,696,009.50
Sep 15, 2021	IBRD-78430	Int Charges	29,075.52
Sep 15, 2021	IBRD-78430	Int Charges	1,611,000.40
Sep 15, 2021	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2015	IBRD-78430	Int Charges	43,014.41
Mar 15, 2015	IBRD-78430	Int Charges	2,177,027.50
Mar 15, 2015	IBRD-78430	Loan Repay	123,990.60
Mar 15, 2015	IBRD-78430	Loan Repay	2,696,009.50
Oct 17, 2013	IBRD-78430	Loan Disb	723,728.70
Mar 15, 2014	IBRD-78430	Int Charges	43,652.97
Mar 15, 2014	IBRD-78430	Int Charges	2,177,027.50
Sep 15, 2013	IBRD-78430	Int Charges	41,049.46
Sep 15, 2013	IBRD-78430	Int Charges	2,177,027.50
Sep 15, 2018	IBRD-78430	Loan Repay	123,990.60
Sep 15, 2018	IBRD-78430	Loan Repay	732,476.94
Sep 15, 2018	IBRD-78430	Loan Repay	1,963,532.50
Sep 15, 2018	IBRD-78430	Int Charges	91,288.76
Sep 15, 2018	IBRD-78430	Int Charges	1,872,243.80
Sep 15, 2017	IBRD-78430	Loan Repay	2,030,049.10
Sep 15, 2017	IBRD-78430	Int Charges	70,724.24
Sep 15, 2017	IBRD-78430	Int Charges	1,959,324.90

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Progress towards achievement of PDO	Satisfactory	2013-12-30
Project Management	Satisfactory	2013-12-30
Financial Management	Satisfactory	2013-12-30
Monitoring and Evaluation	Satisfactory	2013-12-30
Counterpart Funding	Highly Satisfactory	2013-12-30
Overall Implementation Progress (IP)	Satisfactory	2013-12-30
Procurement	Moderately Satisfactory	2013-12-30

COMPLETION RATINGS

INDICATOR	IMPLEMENTATION COMPLETION & RESULTS REPORT: 06-26-2014
Outcomes	Substantial
Risk to Development Outcome	Modest
Bank Performance	Moderately Satisfactory
Borrower Performance	Substantial
Government Performance	Substantial
Implementing Agency	Substantial

INDEPENDENT EVALUATION RATINGS

INDICATOR	ICR REVIEW: 12-03-2014	PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome Rating	Satisfactory	N/a
Risk To Development Outcome	Moderate	N/a
Bank Performance	Moderately Satisfactory	N/a
Borrower Performance	Moderately Satisfactory	N/a
Government Performance	Moderately Satisfactory	N/a
Implementing Agency	Moderately Satisfactory	N/a
Icr Quality	Satisfactory	N/a
M&e Quality	Substantial	N/a

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Direct project beneficiaries	Value	0.00	13389008.00	8640000.00
	Date	January 20, 2010	November 14, 2013	December 31, 2013
	Comment	Number of direct beneficiaries	Corresponds to 155% of the targeted population	Number of direct beneficiaries

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

1. Health Situation Rooms Certified	Value	0.00	36.00	38.00
	Date	January 26, 2010	November 14, 2013	December 31, 2013
	Comment		The value is related to the third certification. 36 out of 37 implemented rooms got the certification.

2. Operational Modules of Social Communication (MOCS) implemented (excluding indigenous people)	Value	1.00	90.00	90.00
	Date	January 26, 2010	November 14, 2013	December 31, 2013
	Comment		379 of 455 (84%) MOCS have been certified

3. Operational Modules of Social Communication (MOCS) for indigenous people implemented	Value	1.00	90.00	90.00
	Date	January 26, 2010	November 14, 2013	December 31, 2013
	Comment		36 MOCs of 45 (80%) for indigenous people have been certified

4. Dose of A/H1N1 vaccine applied	Value	1.00	100.00	90.00
	Date	January 26, 2010	November 14, 2013	December 31, 2013
	Comment		Indicator achieved and target surpassed for 2010 - 2011 vaccination campaign.	Goal achieved

5. Dose of Pneumococcal vaccine applied Value 1.00 99.30 85.00
Date January 26, 2010 December 31, 2012 December 31, 2013
Comment Percentage Indicator achieved and target surpassed. Goal achieved
9. Influenza diagnostic laboratory test carried out in 2010 and 2011 Value 0.00 52909.00 54000.00
Date January 26, 2010 November 14, 2013 December 31, 2013
Comment
10. Independent technical audits performed Value 0.00 8.00 8.00
Date January 26, 2010 November 14, 2013 December 31, 2013
Comment

8. Dose of Pneumococcalvaccines included in National Calendar applied	Value	52.00	86.00	80.00
	Date	March 9, 2012	November 14, 2013	December 31, 2013
	Comment		Final values for Pneumococcal vaccine included in National Calendar Year 2012

11. Inpatient treatment provided in hospitalization due to Acute Respiratory Infections	Value	27284.00	40936.00	30000.00
	Date	December 31, 2010	November 14, 2013	December 31, 2013
	Comment		Correspond to Epidemiological Week 52 (2012)

2. Health Situation Rooms - Level II Accredited	Value	0.00	28.00	16.00
	Date	March 9, 2012	November 14, 2013	December 31, 2013
	Comment		The value is related to the third certification. 28 out of 36 certified rooms achieved more than 80% points, surpassing the target.

7. Dose of A/H1N1 included in National Calendar applied	Value	0.00	91.00	80.00
	Date	March 9, 2012	November 14, 2013	December 31, 2013
	Comment		Values for A/H1N1 vaccination included in National Calendar Year 2013.

9. Outpatient treatment provided Value 0.00 99.00 90.00
Date January 26, 2010 November 14, 2013 December 31, 2013
Comment
10. Inpatient treatment provided in hospitalization Value 0.00 0.00 10000.00
Date January 26, 2010 November 14, 2013 December 31, 2013
Comment Output deactivated due to pandemic control
12. Inpatient treatment provided in ICU Value 0.00 0.00 1000.00
Date January 26, 2010 November 14, 2013 December 31, 2013
Comment Output deactivated due to pandemic control and sanitary emergency.

5. Dose of Pneumococcal vaccine applied	Value	1.00	99.30	85.00
	Date	January 26, 2010	December 31, 2012	December 31, 2013
	Comment	Percentage	Indicator achieved and target surpassed.	Goal achieved

9. Outpatient treatment provided	Value	0.00	99.00	90.00
	Date	January 26, 2010	November 14, 2013	December 31, 2013
	Comment

12. Inpatient treatment provided in ICU	Value	0.00	0.00	1000.00
	Date	January 26, 2010	November 14, 2013	December 31, 2013
	Comment		Output deactivated due to pandemic control and sanitary emergency.